Chromadex Stock Price (NASDAQ:CDXC)

Add to My Stocks
$4.57 $0.12 (2.56%) CDXC stock closing price Sep 19, 2017 (Closing)
Prev Close* : $4.69
Market Cap:
$225.4M
Day Low: $4.5
52 Week Low: $2.25
Open: $4.77
Volume: 275463
Day High: $4.77
52 Week High: $4.85
Dividend:
N/A

Latest Stock Market News

Latest Articles

Chromadex News - From Partners

ChromaDex Reports Third Quarter 2016 Financial Results   by Globe Newswire on Nov 10, 2016

CDXC Stockcharts

View CDXC PE ratio, PS ratio stocks charts and compare with peers.
CDXC Chart
Note: Compare Chromadex stock price history with the index and industry peers.

Chromadex Valuation

PS ratio (
price to sales ratio
)
9.43
PB ratio (
price to book ratio
)
13.88

Chromadex Financial Ratios

Asset Turnover
0.79
Receivables Turnover
3.55
Debt to Equity
0.03

CDXC Industry Peers

Company Price Change (%)
Athersys (ATHX)2.550.17 (7.14%)
Nabriva Therapeutics (NBRV)9.190.32 (3.61%)
Stellar Biotech (SBOT)1.130.03 (2.59%)
Cellcyte Genetics (CCYG)00 (0%)
Pathfinder Cell (PFND)00 (0%)
Cellular Dynamics (ICEL)16.550.03 (0.18%)
Repligen (RGEN)44.431.63 (3.54%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)19.251.4 (7.84%)
Athersys (ATHX)2.550.17 (7.14%)
Stemline Therapeutics (STML)11.250.5 (4.65%)
Idera Pharma (IDRA)2.330.1 (4.48%)
Compugen (CGEN)3.650.15 (4.29%)
IOVANCE BIOTHPT (IOVA)8.550.3 (3.64%)
Evogene (EVGN)4.440.15 (3.5%)
Top gainers from Medical-Biomed-Genetics industry
* As of Sep 20, 2017
CompanyPriceChange (%)
MannKind (MNKD)2.020.26 (11.4%)
Heska (HSKA)88.35.69 (6.05%)
Sorrento Therapeutics (SRNE)1.750.1 (5.41%)
Curis (CRIS)1.690.07 (3.98%)
Five Prime Therapeutics (FPRX)35.331.4 (3.81%)
MiMedx (MDXG)13.160.51 (3.73%)
Keryx Biopharma (KERX)7.040.27 (3.69%)
Top losers from Medical-Biomed-Genetics industry
* As of Sep 20, 2017

Chromadex Corp Stock News - Partner Headlines

Chromadex Financial Statements

income statement20162015201420132012
Net Sales or Revenues26.81M22.01M15.31M10.16M11.61M
Net Income-2.92M-2.77M-5.38M-4.41M-11.66M
Total Operating Expense14.16M10.63M10.46M7.42M13.91M
View Chromadex income statement
balance sheet20162015201420132012
Total Assets19.75M18.74M11.6M8.98M9.03M
Total Liabilities9.77M13.47M7.6M3.32M5.04M
Shareholders Equity9.97M5.27M3.99M5.66M3.99M
View Chromadex balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-2.76M-2.2M-0.48M-1.15M-1.5M
Net Cash from (used by) Operating Activities-2.93M-2.11M-2.58M-3.9M-10.11M
Increase (Decrease) in Prop Plant And Equipment-1.5M-0.52M-0.12M0.86M-0.02M
View Chromadex cash flow statement

Chromadex Stock Message Board

Chromadex stock lost -2.56 %, and the last close price as of 19 Sep, 2017 is 4.57 for CDXC stock. Stock price or share price can be used to find the total market value of a company. Chromadex market cap stands at 225.4M as of 19 Sep, 2017. Chromadex valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Chromadex is worth a lot, it will most likely be reflected in an inflated Chromadex stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 275463 shares were traded with a closing stock price of 4.57 as of 19 Sep, 2017, as can be seen from Chromadex stock quote. One can view Chromadex stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of CDXC, view Chromadex stock price history.